Christine Katlama
Expertise in
5
conditions

Christine Katlama

Paris, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
5
conditions
Paris, FR 

Overview

Christine Katlama practices practicing medicine in Paris, France.

Ms. Katlama is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses HIV/AIDS, Sepsis, Hepatitis, and Kaposi Sarcoma.

She is actively involved in clinical research, co-authoring 266 peer reviewed articles and participating in 5 clinical trials.

Gender

Female

Locations

Paris, France
Other Locations
Toulouse, France
Irles, France
France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Randomised Phase II Placebo-controlled Trial of Antiretroviral Therapy (ART) Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs) vs ART Plus Placebo During Primary HIV-1 Infection to Study the Impact on Post-treatment HIV Control.
A Randomised Phase II Placebo-controlled Trial of Antiretroviral Therapy (ART) Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs) vs ART Plus Placebo During Primary HIV-1 Infection to Study the Impact on Post-treatment HIV Control.
Enrollment Status: Recruiting
Publish Date: December 27, 2024
Intervention Type: Drug
Study Phase: Phase 2
Combined Prevention of Sexually Transmitted Infections (STIs) in Men Who Have Sex With Men and Using Oral Tenofovir Disoproxil Fumarate/ Emtricitabine (TDF/FTC) for HIV Pre-Exposure Prophylaxis (PrEP)
Combined Prevention of Sexually Transmitted Infections (STIs) in Men Who Have Sex With Men and Using Oral Tenofovir Disoproxil Fumarate/ Emtricitabine (TDF/FTC) for HIV Pre-Exposure Prophylaxis (PrEP)
Enrollment Status: Completed
Publish Date: April 06, 2026
Intervention Type: Biological, Drug
Study Drugs: Doxycycline, Bexsero® vaccine
Study Phase: Phase 3
An Open-Label, Multi-Centre, Randomised Study to Investigate Integrase Inhibitor Versus Boosted Protease Inhibitor Antiretroviral Therapy for Patients With Advanced HIV Disease
An Open-Label, Multi-Centre, Randomised Study to Investigate Integrase Inhibitor Versus Boosted Protease Inhibitor Antiretroviral Therapy for Patients With Advanced HIV Disease
Enrollment Status: Completed
Publish Date: December 17, 2025
Intervention Type: Drug
Study Drugs: Biktarvy, Symtuza
Study Phase: Phase 3
A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Dolutegravir Plus Lamivudine in HIV-1 Infected Adults Who Are Virologically Suppressed
A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Dolutegravir Plus Lamivudine in HIV-1 Infected Adults Who Are Virologically Suppressed
Enrollment Status: Completed
Publish Date: July 19, 2023
Intervention Type: Drug
Study Drugs: Dolutegravir+Lamivudine, Tenofovir alafenamide based regimen
Study Phase: Phase 3
Prevention of HIV in Île-de-France
Prevention of HIV in Île-de-France
Enrollment Status: Unknown
Publish Date: June 02, 2022
Intervention Type: Drug
Study Phase: Not Applicable
View 4 Less Clinical Trials

266 Total Publications

Doravirine Resistance Patterns Identified through Week 192 in the DRIVE-FORWARD and DRIVE-AHEAD Phase 3 Clinical Trials.
Doravirine Resistance Patterns Identified through Week 192 in the DRIVE-FORWARD and DRIVE-AHEAD Phase 3 Clinical Trials.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: October 23, 2025

Frequently Asked Questions about Christine Katlama

Is Christine Katlama a top-rated expert for HIV/AIDS?

MediFind is an objective health platform that identifies experts based on real-world data. Christine Katlama is classified as an Elite expert for HIV/AIDS, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Christine Katlama participate in research or clinical trials?

Yes. Christine Katlama has published 266 articles and abstracts on conditions like HIV/AIDS. You can view a list of Christine Katlama's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Katlama's expertise for a condition
ConditionClose
View All 22 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile